{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:26:27Z","timestamp":1793784387785,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cbpa.2026.102763","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:49:14Z","timestamp":1790297354000},"page":"102763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peptide-mediated CRISPR delivery: From dish to bloodstream"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-1525","authenticated-orcid":false,"given":"Alzbeta","family":"Ressnerova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-5540","authenticated-orcid":false,"given":"Ross C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2026.102763_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41434-025-00573-2","article-title":"Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery","volume":"33","author":"Gil","year":"2026","journal-title":"Gene Ther"},{"key":"10.1016\/j.cbpa.2026.102763_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202401632","article-title":"Lipid nanoparticles for delivery of CRISPR gene editing components","volume":"10","author":"Wu","year":"2026","journal-title":"Small Methods"},{"key":"10.1016\/j.cbpa.2026.102763_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2026.2614125","article-title":"Non-viral CRISPR carriers: transient delivery with lasting effects","volume":"33","author":"Lummerstorfer","year":"2026","journal-title":"Drug Deliv"},{"key":"10.1016\/j.cbpa.2026.102763_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41587-025-02945-w","article-title":"Targeted delivery of genome editors in vivo","volume":"44","author":"Ngo","year":"2026","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2026.102763_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2026.102763_bib6","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1093\/nar\/27.17.3510","article-title":"A novel potent strategy for gene delivery using a single peptide vector as a carrier","volume":"27","author":"Morris","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2026.102763_bib7","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1096\/fj.06-6502com","article-title":"Delivery of short interfering RNA using endosomolytic cell-penetrating peptides","volume":"21","author":"Lundberg","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.cbpa.2026.102763_bib8","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/nar\/25.14.2730","article-title":"A new peptide vector for efficient delivery of oligonucleotides into mammalian cells","volume":"25","author":"Morris","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2026.102763_bib9","first-page":"113","article-title":"Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA","author":"Ramakrishna","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.cbpa.2026.102763_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/hum.2024.020","article-title":"Cell-penetrating peptides and CRISPR-Cas9: a combined strategy for human genetic disease therapy","volume":"35","author":"de Morais Ccp","year":"2024","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cbpa.2026.102763_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195558","article-title":"Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9\/Cpf1 ribonucleoproteins in hard-to-modify cells","volume":"13","author":"Del\u2019Guidice","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2026.102763_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41551-023-01032-2","article-title":"Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes","volume":"7","author":"Foss","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.cbpa.2026.102763_bib13","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41596-025-01154-8","article-title":"Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells","volume":"20","author":"Sahu","year":"2025","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cbpa.2026.102763_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41587-023-01756-1","article-title":"Efficient engineering of human and mouse primary cells using peptide-assisted genome editing","volume":"42","author":"Zhang","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2026.102763_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114038","article-title":"Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types","volume":"386","author":"Gustafsson","year":"2025","journal-title":"J Contr Release"},{"key":"10.1016\/j.cbpa.2026.102763_sref20","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202501532","article-title":"Versatile cell penetrating peptide for multimodal CRISPR gene editing in primary stem cells","volume":"36","author":"Graham","year":"2026","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.cbpa.2026.102763_bib17","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1021\/jacs.3c01902","article-title":"Chemical evolution of amphiphilic xenopeptides for potentiated Cas9 ribonucleoprotein delivery","volume":"145","author":"Lin","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.cbpa.2026.102763_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106983","article-title":"Dual pH-responsive CRISPR\/Cas9 ribonucleoprotein xenopeptide complexes for genome editing","volume":"205","author":"Luo","year":"2025","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.cbpa.2026.102763_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202510441","article-title":"Calcium shock enables efficient and programmable particle delivery for genome editing applications","volume":"13","author":"Vo","year":"2026","journal-title":"Adv Sci"},{"key":"10.1016\/j.cbpa.2026.102763_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137932","article-title":"Stimuli-responsive peptide nanocarriers for tumor-specific CRISPR\/Cas9 delivery and precision genome editing","volume":"697","author":"Wang","year":"2025","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.cbpa.2026.102763_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR\u2014Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cbpa.2026.102763_sref22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113854","article-title":"Lipopeptide-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complexes for gene editing and correction","volume":"383","author":"\u00d6ktem","year":"2025","journal-title":"J Contr Release"},{"key":"10.1016\/j.cbpa.2026.102763_bib23","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/s41467-023-43904-w","article-title":"Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo","volume":"14","author":"Kulhankova","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102763_bib24","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1093\/nar\/gkae819","article-title":"Amphiphilic shuttle peptide delivers base editor ribonucleoprotein to correct the CFTR R553X mutation in well-differentiated airway epithelial cells","volume":"52","author":"Kulhankova","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2026.102763_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/hum.2023.016","article-title":"Genome editing in ferret airway epithelia mediated by CRISPR\/nucleases delivered with amphiphilic shuttle peptides","volume":"34","author":"Luo","year":"2023","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cbpa.2026.102763_sref26","article-title":"Efficient in vivo mammalian neuron editing using peptide-mediated CRISPR enzyme delivery [Internet]","author":"Manohar","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.cbpa.2026.102763_sref27","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41467-024-45998-2","article-title":"Engineering self-deliverable ribonucleoproteins for genome editing in the brain","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102763_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2022.12.057","article-title":"TAxI-peptide targeted Cas12a ribonuclease protein nanoformulations increase genome editing in hippocampal neurons","volume":"354","author":"Sellers","year":"2023","journal-title":"J Contr Release"},{"key":"10.1016\/j.cbpa.2026.102763_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12951-024-02554-w","article-title":"Short cell-penetration peptide conjugated bioreducible polymer enhances gene editing of CRISPR system","volume":"22","author":"Wang","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.cbpa.2026.102763_sref30","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jconrel.2024.11.008","article-title":"Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications","volume":"376","author":"Guzman Gonzalez","year":"2024","journal-title":"J Contr Release"},{"key":"10.1016\/j.cbpa.2026.102763_sref13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2024.04.037","article-title":"Lipo-Xenopeptide Polyplexes for CRISPR\/Cas9 based Gene editing at ultra-low dose","volume":"370","author":"Germer","year":"2024","journal-title":"J Contr Release"},{"key":"10.1016\/j.cbpa.2026.102763_bib32","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41467-017-01408-4","article-title":"A thermostable Cas9 with increased lifetime in human plasma","volume":"8","author":"Harrington","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2026.102763_bib33","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ymthe.2023.06.019","article-title":"Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs","volume":"31","author":"Stahl","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2026.102763_bib34","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1172\/JCI136873","article-title":"Correction of muscular dystrophies by CRISPR gene editing","volume":"130","author":"Chemello","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.cbpa.2026.102763_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-Secretase BACE1 in Alzheimer\u2019s disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cbpa.2026.102763_bib36","first-page":"3","article-title":"The effects of huntingtin-lowering: what do we know so far?","volume":"9","author":"Kaemmerer","year":"2019","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"10.1016\/j.cbpa.2026.102763_bib37","doi-asserted-by":"crossref","first-page":"L231","DOI":"10.1152\/ajplung.90209.2008","article-title":"Ciliated epithelial cell lifespan in the mouse trachea and lung","volume":"295","author":"Rawlins","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cbpa.2026.102763_bib38","article-title":"Brain-wide genome editing via STEP-RNPs for treatment of angelman syndrome [Internet]","author":"Lu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.cbpa.2026.102763_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0306-4522(93)90503-8","article-title":"Extracellular space parameters in the rat neocortex and subcortical white matter during postnatal development determined by diffusion analysis","volume":"55","author":"Lehmenk\u00fchler","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.cbpa.2026.102763_bib40","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0509425103","article-title":"In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space","volume":"103","author":"Thorne","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cbpa.2026.102763_bib41","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.cbpa.2026.102763_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective ORgan targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR\/Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cbpa.2026.102763_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072938","article-title":"A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density","volume":"8","author":"Gray","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2026.102763_bib44","series-title":"StockWatch: Intellia stumbles on news of patient\u2019s severe liver toxicity. GEN - Genetic engineering and biotechnology news [Internet]","author":"Philippidis","year":"2025"},{"key":"10.1016\/j.cbpa.2026.102763_bib48","series-title":"Vertex drops Moderna-partnered inhaled CF candidate [Internet]","author":"Incorvaia","year":"2026"},{"key":"10.1016\/j.cbpa.2026.102763_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","article-title":"Clinical relevance of pre-existing and treatment-induced Anti-Poly(Ethylene glycol) antibodies","volume":"8","author":"Freire","year":"2022","journal-title":"Regener Eng Transl Med"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593126001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593126001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:32:07Z","timestamp":1793781127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593126001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S1367593126001122"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2026.102763","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-mediated CRISPR delivery: From dish to bloodstream","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2026.102763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102763"}}